Skip to main content

Substitution Treatment for Opiate Dependence

  • Chapter
Contemporary Psychiatry
  • 30 Accesses

Abstract

Substitution treatment is a therapeutic option that includes the prescription of agonist substances as an adjunct to medical and psychosocial care. The indication and the duration of treatment are determined on the basis of an individual assessment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Ali R, Auriacombe M, Casas M, Cottier L, Farrell M, Kleiber D, Kreuzer A, Ogborne A, Rehm J, Ward P (1998) Report of the external panel on the evaluation of the swiss scientific studies of medically prescribed narcotics to drug addicts. Report to the World Health Organization, Geneva

    Google Scholar 

  • Arif A, Westermeyer J (1990) Methadone maintenance in the management of opioid dependence. An international review. Praeger, New York

    Google Scholar 

  • Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Bammer G, Dobler-Mikola A, Fleming PH, Strang J, Uchtenhagen A (1999) The heroin prescribing debate: integrating science and politics. Science 284: 1277–1278

    Article  PubMed  CAS  Google Scholar 

  • Bühringer G, Gastpar M, Heinz W, Kovar KA, Ladewig D, Naber D, Täschner KL, Uchtenhagen A, Wanke K (1995) MethadonStandards. Vorschläge zur Qualitätssicherung bei der Methadonsubstitutionim Rahmen der Behandlung von Drogenabhängigen. Enke, Stuttgart

    Google Scholar 

  • Bundesamt für Gesundheit (1985) Methadonbericht. Suchtmittelersatz in der Behandlung Heroinabhängiger in der Schweiz. Bundesamt für Gesundheit, Bern

    Google Scholar 

  • Caplehorn JR (1994) A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int J Addict 29: 1361–1375

    PubMed  CAS  Google Scholar 

  • Chutuape MA, Silverman K, Stitzer ML (1998) Survey assessment of methadone treatment services as reinforcers. Am J Drug Alcohol Abuse 24: 1–16

    Article  PubMed  CAS  Google Scholar 

  • **Cooper JR, Altman F, Brown BS, Czechowicz D (1983) Research on the treatment of narcotic addiction. The state of the art. National Institute of Drug Abuse, Rockville

    Google Scholar 

  • Dees SM, Dansereau DF, Simpson DD (1997) Mapping-enhanced drug abuse counseling: urinalysis results in the first year of methadone treatment. J Subst Abuse Treat 14: 45–54

    Article  PubMed  CAS  Google Scholar 

  • Dolan K, Hall W, Wodak A (1998) The provision of methadone within prison settings. In: Ward J, Mattick RP, Hall W (eds) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam, pp 379–396

    Google Scholar 

  • *Dole V, Nyswander M (1965) A medical treatment for diacetylmorphine (heroin) addiction. JAMA 193: 146–150

    Article  Google Scholar 

  • *Farrell M, Neeleman J, Gossop M, Griffiths P, Buning E, Finch E, Strang J (1996) Drug prevention. A review of the legislation, regulation and delivery of methadone in 12 member states of the European Union. Final report. Office for Official Publications of the European Communities, Brussels

    Google Scholar 

  • Finnegan LP, Hagan T, Kaltenbach KA (1991) Scientific foundation of clinical practice: opiate use in pregnant women. Bull NY Acad Med 67: 223–239

    CAS  Google Scholar 

  • Gossop M (1998) NTORS at one year. The National Treatment Outcome Research Study. Department of Health, London

    Google Scholar 

  • Hartnoll R, Mitcheson M, Battersby A, Brown G, Ellis M, Fleming P, Hedley N (1980) Evaluation of heroin maintenance in a controlled trial. Arch Gen Psychiatr 37: 877–884

    Article  PubMed  CAS  Google Scholar 

  • Hubbard RL, Marsden ME, Rachal JV, Haarwood HJ, Cavanaugh ER, Ginzburg HM (1989) Drug abuse treatment. A national study of effectiveness. University of North Carolina Press, Chapel Hill

    Google Scholar 

  • Kreek MJ (1996) Long-term pharmacotherapy for opiate (primarily heroin) addiction: opioid agonists. In: Schuster CH, Kuhar MJ (eds) Pharmacological aspects of drug dependence. Toward an integrated neurobehavioral approach. Springer, Berlin Heidelberg New York, pp 487–562

    Chapter  Google Scholar 

  • Lifschitz MH, Wilson GS, Smith EO, Desmond MM (1985) Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 75: 269–274

    PubMed  CAS  Google Scholar 

  • Ling W, Klett JC, Gillis RC (1980) A cooperative clinical study of methadyl acetate. Arch Gen Psychiatry 37: 908–911

    Article  PubMed  CAS  Google Scholar 

  • Maddux JF, Desmond DP, Esquivel M (1995) Rapid admission and retention on methadone. Am J Drug Alcohol Abuse 21: 533–547

    Article  PubMed  CAS  Google Scholar 

  • Mattick RP, Oliphant D, Ward J, Hall W (1998) The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance. In Ward J, Mattick RP, Hall W (eds) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam, pp 123–160

    Google Scholar 

  • *McLellan AT, Arndt IO, Metzger IS, Woody GE, O’Brien CP (1993) The effects of psychosocial services in substance abuse treatment. JAMA 269: 1953–1959

    Article  PubMed  CAS  Google Scholar 

  • Metrebian N, Shanahan W, Wells B, Stimson GV (1998) Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Med J Aust 168: 596–600

    PubMed  CAS  Google Scholar 

  • Mino A (1990) Analyse scientifique de la litérature sur la remise contrôlée d’héroïne ou de morphine. Institutions universitaires de psychiatrie, Geneva

    Google Scholar 

  • Parrino MW (1991) State methadone treatment guidelines. U.S. Department of Health and Human Services, Rockville

    Google Scholar 

  • *Raschke P (1994) Substitutionstherapie. Ergebnisse langfristiger Behandlung von Opiatabhängigen. Lambertus, Freiburg im Breisgau

    Google Scholar 

  • Rhoades HM, Creson D, Elk R, Schmitz J, Grabowsk J (1998) Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 88: 34–39

    Article  PubMed  CAS  Google Scholar 

  • Robinson GM, Dukes PD, Robinson BJ, Cook RR, Mahoney GN (1993) The misuse of buprenorphine and buprenorphinenaloxone combination in Wellington, New Zealand. Drug Alcohol Dependence 33: 81–86

    Article  PubMed  CAS  Google Scholar 

  • Ruel JM (1996) International survey on the use of methadone in the treatment of narcotic addiction. Bureau of Drug Surveillance, Ottawa

    Google Scholar 

  • Savage C, Karp EG, Curran SF, Hanlon TE, McCabe OL (1976) Methadone/LAAM maintenance: a comparison study. Compr Psychiatry 17: 415–424

    Article  PubMed  CAS  Google Scholar 

  • Scott RTA, Jay MJH, Keith R, Oliver JS, Cassidy MT (1999) A confidential enquiry into methadone-related deaths. Addiction 94: 1789–1794

    Article  PubMed  CAS  Google Scholar 

  • *Seidenberg A, Honegger U (1998) Methadon, Heroin und andere Opioide. Medizinisches Manual für die ambulante opioidgestützte Behandlung. Huber, Bern

    Google Scholar 

  • Senay EC, Uchtenhagen A (1990) Methadone in the treatment of opioid dependence. In: Arif A, Westermeyer J (eds) Methadone maintenance in the management of opioid dependence. Praeger, New York, pp 19–54

    Google Scholar 

  • Senay EC, Barthwell A, Marks R, Bokos PJ (1994) Medical maintenance: an interim report. J Addict Di 13: 65–69

    Article  CAS  Google Scholar 

  • Simpson DD, Curry SJ (eds) (1997) Drug Abuse Treatment Outcome Study DATOS. Psychol Addict Behav 11 (special issue): 4

    Google Scholar 

  • Simpson DD, Sells SB (1990) Opioid addiction and treatment: a 12-year follow-up. Krieger, Malabar

    Google Scholar 

  • Simpson DD, Joe GW, Dansereau DF, Chatham LR (1997) Strategies for improving methadone treatment process and outcomes. J Drug Issues 27: 239–260

    Google Scholar 

  • Stitzer ML, Iguchi MY, Felch LJ (1992) Contingent take-home incentive: effects on drug use of methadone. J Consulting Clin Psychol 60: 927–934

    Article  CAS  Google Scholar 

  • Strang J, Gossop M (1996) Heroin prescribing in the British system: a historical review. Eur Addict Res 2: 185–193

    Article  Google Scholar 

  • Svikis DS, Lee JH, Haug NA, Stitzer ML (1997) Attendance incentives for outpatient treatment: effects in methadoneand nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Dependence 48: 33–41

    Article  PubMed  CAS  Google Scholar 

  • Tennant FS, Rawson RA, Pumphrey E, Seecof R (1986) Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM). J Subst Abuse Treat 3: 195–202

    Article  PubMed  Google Scholar 

  • *Uchtenhagen A, Zimmer-Höfler D (1985) Heroinabhängige und ihre normalen Altersgenossen. Herkunft, Lebenssituation, Zweijahresverlauf im Quervergleich. Haupt, Bern

    Google Scholar 

  • Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blättler R, Pfeifer S (1999) Prescription of narcotics for heroin addicts. Main results of the Swiss National Cohort Study. Karger, Basel

    Google Scholar 

  • van Brüssel G (1995) Le programme de distribution de morphine a Amsterdam: experiences pratiques. In: Rihs-Middel M, Clerc J, Stamm R (eds) La préscription de stupéfiants sous contrôle médical. Editions Médecine et Hygiène, Geneva, pp 161–167

    Google Scholar 

  • van Rhee JM (1998) Study on the effectiveness of medically coprescribed heroin. Progress report. Central Committee on the Treatment of Heroin Addicts, Utrecht

    Google Scholar 

  • Verthein U, Degkwitz P, Haasen C, Raschke P, Krausz M (1996) Die Substitutionsbehandlung Opiatabhängiger mit Codein/ Dihydrocodein und Methadon ein Kontrollgruppenvergleich. Sucht 42: 108–115

    Google Scholar 

  • Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE (1994) Clinical pharmacology of buprenorphine. Ceiling effects at high doses. Clin Pharmacol Ther 55: 569–580

    Article  PubMed  CAS  Google Scholar 

  • *Ward J, Mattick R, Hall W (1998) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam

    Google Scholar 

  • WHO (1989) Options for the use of methadone in the treatment of drug dependence. World Health Organization, Geneva (WHO/MNH/DAT/89/2)

    Google Scholar 

  • WHO (1998) WHO Expert Committee on Drug Dependence. Thirtieth Report. World Health Organization, Geneva (Technical report series 873)

    Google Scholar 

  • Woody GE, McLellan AT, Luborsky LO, Brien CP (1995) Psychotherapy in community methadone programs: a validation study. Am J Psychiatr 152: 1302–1308

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Uchtenhagen, A. (2001). Substitution Treatment for Opiate Dependence. In: Henn, F., Sartorius, N., Helmchen, H., Lauter, H. (eds) Contemporary Psychiatry. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59519-6_139

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59519-6_139

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64007-0

  • Online ISBN: 978-3-642-59519-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics